Return to homepagePandemic Pact

Production of recombinant antibodies against the SARS-CoV-2 virus from memory B lymphocytes of patients recovered from COVID-19: Development of a therapeutic tool

  • Funded by Consejo Nacional de Ciencia y Tecnología (CONACYT)
  • Total publications:3 publications

Grant number: 312677

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Consejo Nacional de Ciencia y Tecnología (CONACYT)

  • Research Location

    Mexico

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Research, Development And Innovation Of Effective And Affordable Therapeutic Alternatives

3 Publications linked via Europe PMC

Last Updated:3 days ago

View all publications at Europe PMC

Single-cell transcriptomic analysis of B cells reveals new insights into atypical memory B cells in COVID-19.

Neutralization of Omicron BA.1, BA.5.1.6, BQ.1.3 and XBB1.1 induced by heterologous vaccination Ad5-nCoV and mRNA-1273.

19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern.